OtherBASIC SCIENCE INVESTIGATIONS
A Novel Method of 18F Radiolabeling for PET
William J. McBride, Robert M. Sharkey, Habibe Karacay, Christopher A. D'Souza, Edmund A. Rossi, Peter Laverman, Chien-Hsing Chang, Otto C. Boerman and David M. Goldenberg
Journal of Nuclear Medicine June 2009, 50 (6) 991-998; DOI: https://doi.org/10.2967/jnumed.108.060418
William J. McBride
Robert M. Sharkey
Habibe Karacay
Christopher A. D'Souza
Edmund A. Rossi
Peter Laverman
Chien-Hsing Chang
Otto C. Boerman
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 50, Issue 6
June 2009
A Novel Method of 18F Radiolabeling for PET
William J. McBride, Robert M. Sharkey, Habibe Karacay, Christopher A. D'Souza, Edmund A. Rossi, Peter Laverman, Chien-Hsing Chang, Otto C. Boerman, David M. Goldenberg
Journal of Nuclear Medicine Jun 2009, 50 (6) 991-998; DOI: 10.2967/jnumed.108.060418
Jump to section
Related Articles
Cited By...
- Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
- FAPI-74 PET/CT Using Either 18F-AlF or Cold-Kit 68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
- Clinical Translation of a 68Ga-Labeled Integrin {alpha}v{beta}6-Targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer
- Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors
- 18F-AlF-Labeled Biomolecule Conjugates as Imaging Pharmaceuticals
- Recent Advances in 18F Radiochemistry: A Focus on B-18F, Si-18F, Al-18F, and C-18F Radiofluorination via Spirocyclic Iodonium Ylides
- Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial
- Clinical Translation of an Albumin-Binding PET Radiotracer 68Ga-NEB
- In Vivo Evaluation of 18F-SiFAlin-Modified TATE: A Potential Challenge for 68Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET
- Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer
- Effect of Chelate Type and Radioisotope on the Imaging Efficacy of 4 Fibrin-Specific PET Probes
- In Vivo Labeling of Serum Albumin for PET
- Al18F Labeling of Affibody Molecules
- A Comparative Study of Radiolabeled Bombesin Analogs for the PET Imaging of Prostate Cancer
- Three Methods for 18F Labeling of the HER2-Binding Affibody Molecule ZHER2:2891 Including Preclinical Assessment
- Al18F: A New Standard for Radiofluorination
- Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement
- PET of Tumors Expressing Gastrin-Releasing Peptide Receptor with an 18F-Labeled Bombesin Analog
- Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with 18F-Labeled Affibody Molecule ZHER2:2395 in a Mouse Model for Ovarian Cancer
- Assessing Antibody Pharmacokinetics in Mice with In Vivo Imaging
- Pretargeted Immuno-Positron Emission Tomography Imaging of Carcinoembryonic Antigen-Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts
- A Novel Facile Method of Labeling Octreotide with 18F-Fluorine